| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Nov 24 | LCTX Lineage Cell Therapeutics | Common Shares | Buy | Acquire P | No | No | 0.6 | 15,000 | 9.00 k | 22,184 |
| 7 Mar 24 | LCTX Lineage Cell Therapeutics | Employee Stock Option Common Shares | Grant | Acquire A | No | No | 1.13 | 650,000 | 734.50 k | 650,000 |
| 11 Feb 24 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Payment of exercise | Dispose F | No | No | 1.08 | 2,490 | 2.69 k | 7,184 |
| 11 Feb 24 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Option exercise | Acquire M | No | No | 0 | 6,076 | 0.00 | 9,674 |
| 11 Feb 24 | LCTX Lineage Cell Therapeutics | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 6,076 | 0.00 | 12,151 |
